EXJADE 360 mg, comprimé pelliculé — plaquette(s) thermoformée(s) PVC PVDC aluminium de 30 comprimé(s)

Medicine package · Base de données publique des médicaments (BDPM), ANSM, HAS et Assurance Maladie · France

  • CIP13 3400930061763
  • CIP7 3006176
  • CIS 65539020
  • Registration number EU/1/06/356

What the source publishes

Holder
NOVARTIS EUROPHARM (IRLANDE)
Active ingredients
DÉFÉRASIROX
Form
comprimé pelliculé
Package
plaquette(s) thermoformée(s) PVC PVDC aluminium de 30 comprimé(s)
Routes
orale
Administrative status
authorised
Supply regime
médicament nécessitant une surveillance particulière pendant le traitement ; prescription initiale hospitalière semestrielle ; liste I ; renouvellement non restreint
Marketing status
Déclaration de commercialisation
Authorised on
2016-03-22
Prescription
Prescription or restricted

Names this record is found by

Complete source data
fr:ansm:packages:3400930061763
{
  "cis": "65539020",
  "cip7": "3006176",
  "form": "comprimé pelliculé",
  "name": "EXJADE 360 mg, comprimé pelliculé — plaquette(s) thermoformée(s) PVC PVDC aluminium de 30 comprimé(s)",
  "cip13": "3400930061763",
  "holder": "NOVARTIS EUROPHARM (IRLANDE)",
  "routes": [
    "orale"
  ],
  "holders": [
    "NOVARTIS EUROPHARM (IRLANDE)"
  ],
  "currency": "EUR",
  "marketed": true,
  "bdmStatus": null,
  "useDomain": "unknown",
  "publicPrice": "263.08",
  "authorisedOn": "2016-03-22",
  "compositions": [
    {
      "name": "DÉFÉRASIROX",
      "nature": "SA",
      "strength": "360 mg",
      "linkageNumber": "1",
      "substanceCode": "87487",
      "dosageReference": "un comprimé",
      "pharmaceuticalElement": "comprimé"
    }
  ],
  "sourceStatus": "Présentation active",
  "supplyRegime": "médicament nécessitant une surveillance particulière pendant le traitement ; prescription initiale hospitalière semestrielle ; liste I ; renouvellement non restreint",
  "dispensingFee": "1.02",
  "medicinePrice": "262.06",
  "regionalRules": "not-collected",
  "targetSpecies": [],
  "specialityName": "EXJADE 360 mg, comprimé pelliculé",
  "marketingStatus": "Déclaration de commercialisation",
  "publicationDates": {
    "CIS_bdpm": "2026-01-08",
    "CIS_CIP_bdpm": "2026-11-19",
    "CIS_CPD_bdpm": "2026-01-08",
    "CIS_COMPO_bdpm": "2026-01-08"
  },
  "specialityListed": true,
  "useDomainEvidence": {
    "basis": "unreviewed",
    "field": null,
    "value": null,
    "version": 1,
    "sourceId": "fr.ansm.bdpm"
  },
  "collectiveApproval": "oui",
  "packageDescription": "plaquette(s) thermoformée(s) PVC PVDC aluminium de 30 comprimé(s)",
  "patientEligibility": "not-assessed",
  "reimbursementRates": [
    "65%"
  ],
  "marketingDeclaredOn": "2018-01-26",
  "targetSpeciesStatus": "not-reported",
  "additionalMonitoring": true,
  "administrativeStatus": "authorised",
  "prescriptionCategory": "prescription-or-restricted",
  "activeIngredientNames": [
    "DÉFÉRASIROX"
  ],
  "authorisationProcedure": "Procédure centralisée",
  "prescriptionConditions": [
    "médicament nécessitant une surveillance particulière pendant le traitement",
    "prescription initiale hospitalière semestrielle",
    "liste I",
    "renouvellement non restreint"
  ],
  "reimbursementIndications": null,
  "authorisationSourceStatus": "Autorisation active",
  "europeanAuthorisationNumber": "EU/1/06/356",
  "presentationAdministrativeStatus": "authorised"
}

Read this record from your own software

The same record, with every field and its provenance, is one request away. An API key is free and works immediately.

GET /v1/drugs/record
curl -G "https://api.medifontis.com/v1/drugs/record" \
  -H "Authorization: Bearer $MEDIFONTIS_API_KEY" \
  --data-urlencode "country=fr" \
  --data-urlencode "sourceId=fr.ansm.bdpm" \
  --data-urlencode "id=fr:ansm:packages:3400930061763"